Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 294

1.

MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.

Larmonie NSD, Arentsen-Peters TCJM, Obulkasim A, Valerio D, Sonneveld E, Danen-van Oorschot AA, de Haas V, Reinhardt D, Zimmermann M, Trka J, Baruchel A, Pieters R, van den Heuvel-Eibrink MM, Zwaan CM, Fornerod M.

Oncogene. 2017 Sep 11. doi: 10.1038/onc.2017.293. [Epub ahead of print]

PMID:
28892045
2.

The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, Van der Lely AJ, Johannsson G, Neggers SJCMM.

Eur J Endocrinol. 2017 Sep 7. pii: EJE-17-0387. doi: 10.1530/EJE-17-0387. [Epub ahead of print]

PMID:
28882980
3.

Frequency and characteristics of pulmonary nodules in children at computed tomography.

Samim A, Littooij AS, van den Heuvel-Eibrink MM, Wessels FJ, Nievelstein RAJ, de Jong PA.

Pediatr Radiol. 2017 Sep 4. doi: 10.1007/s00247-017-3946-2. [Epub ahead of print]

PMID:
28871322
4.

C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.

Marneth AE, Prange KHM, Al Hinai ASA, Bergevoet SM, Tesi N, Janssen-Megens E, Kim B, Sharifi N, Yaspo ML, Kuster J, Sanders MA, Stoetman ECG, Knijnenburg J, Peters TCJM, Zwaan CM, Stunnenberg HG, van den Heuvel-Eibrink MM, Haferlach T, Fornerod M, Jansen JH, Valk PJM, van der Reijden BA, Martens JHA.

Leukemia. 2017 Sep 5. doi: 10.1038/leu.2017.280. [Epub ahead of print]

PMID:
28871137
5.

Very Long-term Sequelae After Nonradical Surgery Combined With Brachytherapy in an Infant With a Chemotherapy-resistant Rhabdomyosarcoma of the Tongue.

van Rijswijk PM, van den Heuvel-Eibrink MM, van den Akker ELT, Slagter C, Lequin MH, Aarsen FK, van Atteveld JE, Wagner A, van Grotel M.

J Pediatr Hematol Oncol. 2017 Oct;39(7):566-569. doi: 10.1097/MPH.0000000000000935.

PMID:
28859029
6.

The MLL recombinome of acute leukemias in 2017.

Meyer C, Burmeister T, Gröger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, Delabesse E, Park TS, Oh SH, Silva MLM, Lund-Aho T, Juvonen V, Moore AS, Heidenreich O, Vormoor J, Zerkalenkova E, Olshanskaya Y, Bueno C, Menendez P, Teigler-Schlegel A, Zur Stadt U, Lentes J, Göhring G, Kustanovich A, Aleinikova O, Schäfer BW, Kubetzko S, Madsen HO, Gruhn B, Duarte X, Gameiro P, Lippert E, Bidet A, Cayuela JM, Clappier E, Alonso CN, Zwaan CM, van den Heuvel-Eibrink MM, Izraeli S, Trakhtenbrot L, Archer P, Hancock J, Möricke A, Alten J, Schrappe M, Stanulla M, Strehl S, Attarbaschi A, Dworzak M, Haas OA, Panzer-Grümayer R, Sedék L, Szczepański T, Caye A, Suarez L, Cavé H, Marschalek R.

Leukemia. 2017 Jul 13. doi: 10.1038/leu.2017.213. [Epub ahead of print]

PMID:
28701730
7.

Apparent diffusion coefficient as it relates to histopathology findings in post-chemotherapy nephroblastoma: a feasibility study.

Littooij AS, Nikkels PG, Hulsbergen-van de Kaa CA, van de Ven CP, van den Heuvel-Eibrink MM, Olsen ØE.

Pediatr Radiol. 2017 Jul 1. doi: 10.1007/s00247-017-3931-9. [Epub ahead of print]

PMID:
28669064
8.

The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.

Gutierrez-Camino A, Oosterom N, den Hoed MAH, Lopez-Lopez E, Martin-Guerrero I, Pluijm SMF, Pieters R, de Jonge R, Tissing WJE, Heil SG, García-Orad A, van den Heuvel-Eibrink MM.

Pharmacogenet Genomics. 2017 Aug;27(8):303-306. doi: 10.1097/FPC.0000000000000291.

PMID:
28628559
9.

Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.

Warris LT, van den Akker ELT, Bierings MB, van den Bos C, Aarsen FK, Zwaan MC, Tissing WJE, Veening MA, Pieters R, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2017 Jun 9. doi: 10.1002/pbc.26679. [Epub ahead of print]

PMID:
28598548
10.

Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.

Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM; DCOG LATER Study Group.

J Clin Oncol. 2017 Jul 10;35(20):2288-2298. doi: 10.1200/JCO.2016.71.6902. Epub 2017 May 22.

PMID:
28530852
11.

Demodicosis in Pediatric Cancer.

van Atteveld JE, Graaf M, Grotel MV, van den Heuvel-Eibrink MM.

J Pediatr Hematol Oncol. 2017 Jul;39(5):402-406. doi: 10.1097/MPH.0000000000000836.

PMID:
28486260
12.

Recurrently affected genes in juvenile myelomonocytic leukaemia.

Obenauer JC, Kavelaars FG, Sanders MA, de Vries ACH, de Haas V, Beverloo HB, De Moerloose B, Lammens T, Dworzak M, Hoogenboezem RM, Valk PJM, Touw IP, van den Heuvel-Eibrink MM.

Br J Haematol. 2017 May 9. doi: 10.1111/bjh.14737. [Epub ahead of print] No abstract available.

PMID:
28485469
13.

Feeding strategies in pediatric cancer patients with gastrointestinal mucositis: a multicenter prospective observational study and international survey.

Kuiken NSS, Rings EHHM, van den Heuvel-Eibrink MM, van de Wetering MD, Tissing WJE.

Support Care Cancer. 2017 Apr 26. doi: 10.1007/s00520-017-3715-7. [Epub ahead of print]

14.

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.

Obulkasim A, Katsman-Kuipers JE, Verboon L, Sanders M, Touw I, Jongen-Lavrencic M, Pieters R, Klusmann JH, Michel Zwaan C, van den Heuvel-Eibrink MM, Fornerod M.

Oncotarget. 2017 May 16;8(20):33078-33085. doi: 10.18632/oncotarget.16525.

15.

RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152.

Ronckers CM, Tytgat L, van den Heuvel-Eibrink MM, Teepen J, Kremer LCM, Clement S, van Santen HM.

Eur J Cancer. 2017 May;77:21-23. doi: 10.1016/j.ejca.2017.02.019. Epub 2017 Mar 27. No abstract available.

PMID:
28359832
16.

Very long-term sequelae of craniopharyngioma.

Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely AJ, Neggers SJCMM.

Eur J Endocrinol. 2017 Jun;176(6):755-767. doi: 10.1530/EJE-17-0044. Epub 2017 Mar 21.

PMID:
28325825
17.

Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, Boekhout A, Borgmann-Staudt A, Brown MC, Cohn R, Dirksen U, Giwercman A, Ishiguro H, Jahnukainen K, Kenney LB, Loonen JJ, Meacham L, Neggers S, Nussey S, Petersen C, Shnorhavorian M, van den Heuvel-Eibrink MM, van Santen HM, Wallace WH, Green DM.

Lancet Oncol. 2017 Feb;18(2):e75-e90. doi: 10.1016/S1470-2045(17)30026-8. Review.

PMID:
28214419
18.

Congenital mesoblastic nephroma 50 years after its recognition: A narrative review.

Gooskens SL, Houwing ME, Vujanic GM, Dome JS, Diertens T, Coulomb-l'Herminé A, Godzinski J, Pritchard-Jones K, Graf N, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26437. Epub 2017 Jan 26. Review.

PMID:
28124468
19.

Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.

de Rooij JD, Branstetter C, Ma J, Li Y, Walsh MP, Cheng J, Obulkasim A, Dang J, Easton J, Verboon LJ, Mulder HL, Zimmermann M, Koss C, Gupta P, Edmonson M, Rusch M, Lim JY, Reinhardt K, Pigazzi M, Song G, Yeoh AE, Shih LY, Liang DC, Halene S, Krause DS, Zhang J, Downing JR, Locatelli F, Reinhardt D, van den Heuvel-Eibrink MM, Zwaan CM, Fornerod M, Gruber TA.

Nat Genet. 2017 Mar;49(3):451-456. doi: 10.1038/ng.3772. Epub 2017 Jan 23.

PMID:
28112737
20.

Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre study.

Postema FA, Hopman SM, de Borgie CA, Hammond P, Hennekam RC, Merks JH; TuPS study group, Aalfs CM, Anninga JK, Berger LP, Bleeker FE, de Bont ES, de Borgie CA, Dommering CJ, van Eijkelenburg NK, Hammond P, Hennekam RC, van den Heuvel-Eibrink MM, Hopman SM, Jongmans MC, Kors WA, Letteboer TG, Loeffen JL, Merks JH, Olderode-Berends MJ, Postema FA, Wagner A; TuPS study group.

BMJ Open. 2017 Jan 20;7(1):e013237. doi: 10.1136/bmjopen-2016-013237.

Supplemental Content

Loading ...
Support Center